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Introduction
Amyloid light-chain (AL) amyloidosis has an annual inci-
dence of 6–10 cases per million in the USA with cardiac in-
volvement occurring in 90%.1) The clinical presentation of 
cardiac amyloidosis (CA) in the form of heart failure due to re-
strictive infiltrative cardiomyopathy is well described. Less of-
ten patients present with myocardial ischemic syndromes 
which is thought to be due to amyloid obstruction of the in-
tramyocardial coronary arteries.2) Little has been published on 
the effect of CA on microcirculatory function. Here we dem-
onstrate a reduction of myocardial blood flow reserve (MBFR) 
in a patient with CA using real-time myocardial contrast echo-
cardiography (MCE).
Case
A 52-year-old lady who presented with breathlessness and 
mild left ventricular impairment with severe biventricular thick-
ening on echocardiography. There was no past medical history 
of note and blood pressure assessment was normal. Haemato-
logical investigations revealed systemic light chain (AL) amy-
loidosis. Cardiac magnetic resonance imaging (CMR) showed 
biatrial and biventricular extensive subendocardial delayed en-
hancement typical for CA (Fig. 1). Although endomyocardial 
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biopsy was not performed, the diagnosis of CA was based on 
confirmed plasma-cell dyscrasia with presence of amyloid in 
bone marrow biopsy, and typical amyloid CMR (CMR carries 
92% positive predictive value).3) Additionally, repeat echocar-
diogram and CMR following chemotherapy showed restora-
tion of left ventricular systolic function and reduction in sub-
endocardial delayed enhancement. The patient had a normal 
coronary angiogram one year previously for investigation of 
chest pain. After developing further atypical chest pains she 
was referred for dipyridamole stress echocardiography to assess 
for wall motion abnormality, which was negative. We subse-
quently performed vasodilator MCE to assess myocardial blood 
flow (MBF) at baseline, MBF at peak stress (MBFs) and MBFR. 
MBFR is a validated technique in the assessment of microvascu-
lar function in the absence of obstructive coronary artery dis-
ease first reported by Wei et al.4) in 2001. Real-time MCE was 
performed according to an established protocol using a com-
mercial ultrasound machine (iE33, Philips Medical Systems, 
Best, the Netherlands) and SonoVue (Bracco Research SA, Ge-
neva, Switzerland) contrast agent with a rate set between 0.8–
1.0 mL/min to maximize image quality with minimal attenua-
tion.5) Images were recorded in the 3 apical views with low-
power settings at a mechanical index of 0.1. Flash-impulse 
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imaging at a high mechanical index (1.0) was performed to 
achieve complete myocardial bubble destruction, after which 
10 end-systolic frames were recorded digitally in each view. 
Imaging was repeated after dipyridamole infusion at 0.56 mg/
kg over a 4-minute period. After an interval of 2 minutes, di-
pyridamole vasodilator images were recorded within 3 to 4 
minutes. Excellent image quality was obtained with all 16 left 
ventricular segments adequately visualized. Quantitative anal-
ysis was performed by an investigator who was blinded to the 
CMR data. Standard commercial software (Qlab version 7.0, Q-
Laboratory, Philips Medical Systems, Best, the Netherlands) 
was used to study regions of interest within the myocardium and 
quantify myocardial replenishment as previously described.4) 
Basal segments of the 16-segment left ventricular model were 
not included in the quantitative analysis.
Background-subtracted plots of peak myocardial contrast in-
tensity (representing myocardial blood volume A, dB) versus 
pulsing intervals (representing time) were automatically con-
structed by QLab software to fit the monoexponential func-
tion conventional equation: y = A (1 - e-βt)2. From these plots, 
the slope of the replenishment curve was determined (repre-
senting myocardial blood velocity β, dB/s). Per segment, the 
product of A and β yielded rest MBF and post-dipyridamole 
MBFs (stress MBF, dB2/s), respectively. The replenishment curves 
are presented in Fig. 2. MBFR was calculated as the ratio of 
peak MBF to resting MBF.
The replenishment pictures are shown in Fig. 3. Although 
steady state perfusion at rest and peak stress appears homoge-
nous throughout the myocardium the rate of replenishment fol-
lowing bubble destruction at rest and peak stress is signifi-
cantly reduced. The peak myocardial blood velocity β was 
therefore less than normal healthy studies. Although the peak 
MBF increased (26.9 dB2/s vs. 43.9 dB2/s) the MBFR was only 
1.6 (normal > 2).6)
Discussion
CA is a rare condition associated with primary light chain 
(AL) amyloidosis. The impairment in MBF observed in CA 
has been described in two small case studies previously and is 
thought to be due to obstruction of the intramyocardial coro-
nary arterial lumen by amyloid deposition.2) In contrast, al-
though the larger epicardial arteries show evidence of amyloi-
dosis in the arterial walls, the lumen of these vessels are almost 
always unobstructed. Vascular deposition of amyloid, although 
not as common as interstitial type, is well described in the lit-
erature.2)7) The intramyocardial arteries are selectively affected 
with deposition first beginning in the media and then progress-
ing to the adventitia.1) Eventually, luminal obstruction occurs 
and in one series was shown to be histologically present in two 
thirds of patients studied.2) This effect is thought to be the cause 
of the anginal symptoms described and be responsible for the 
ischemic histological changes seen in the majority of amyloid 
Fig. 1. Cardiac MR four chamber view showing biatrial and biventricular 
subendocardial delayed enhancement in keeping with a diagnosis of 
cardiac amyloidosis.
Fig. 2. Replenishment curves following bubble destruction using high 
amplitude ultrasound pulse at rest (A) and post-dipyridamole (stress) (B). 
A normal study curve has also been plotted for comparison, taken from 
previous published data by our group.5) Peak video intensity A is 
proportional to and therefore representative of blood volume. Gradient 
β (dB/s) represents peak blood velocity.
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hearts. It may also explain the chronically elevated troponin lev-
els observed.2)7)8)
Real time MCE with flash bubble destruction is a well-vali-
dated diagnostic tool to quantify MBFR.9) Two previous stud-
ies have examined MBF in patients with CA. Al Suwaidi et 
al.10) undertook coronary angiography in five patients with CA 
and measured coronary flow reserve using adenosine and then 
acetylcholine. Although all had normal epicardial arteries, both 
endothelial independent and endothelial dependent functions 
were significantly impaired. In a second study, a single case of 
amyloid underwent MCE with vasodilator stress in which 
MBF was also impaired.11) This report further demonstrates the 
use of this technique in understanding CA pathophysiology. 
In addition we observe that MBFR is lower in our amyloid 
patient because of peak blood velocity β being lower compared 
to healthy population data. Overall, microvascular ischaemia 
resulting from intramyocardial coronary artery obstruction by 
amyloid deposition can be a probable cause of abnormal MBFR 
of CA even without epicardial coronary artery disease. 
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